Guarantor Financial Information (Tables)

3 Months Ended

Mar. 31, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Condensed Consolidating Balance Sheet Information

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

At March 31, 2016

(in thousands, except share and per share amounts)

	inVentiv			Guarantor		Non-Guarantor
	Health, Inc.			Subsidiaries		Subsidiaries		Eliminations			Total
ASSETS
Current assets:
Cash and cash equivalents	$	27,758			—	$	136,644	$	(87,289	)	$	77,113
Restricted cash		1,716			—		838		—			2,554
Accounts receivable, net of allowances for    doubtful accounts		—			266,930		61,396		—			328,326
Unbilled services		—			223,422		38,301		—			261,723
Intercompany receivables		504,621			825,469		84,860		(1,414,950	)		—
Prepaid expenses and other current assets		7,364			19,001		18,694		—			45,059
Income tax receivable		26			—		996		—			1,022
Total current assets		541,485			1,334,822		341,729		(1,502,239	)		715,797
Property and equipment, net		21,369			98,916		18,887		—			139,172
Goodwill		—			855,317		41,448		—			896,765
Intangible assets, net		—			319,311		6,608		—			325,919
Non-current deferred tax assets		—			—		10,421		—			10,421
Other assets		20,331			4,330		15,060		—			39,721
Non-current intercompany receivables		429,168			28,867		—		(458,035	)		—
Investment in consolidated subsidiaries		700,686			107,127		—		(807,813	)		—
Total assets	$	1,713,039		$	2,748,690	$	434,153	$	(2,768,087	)	$	2,127,795
LIABILITIES AND STOCKHOLDER’S (DEFICIT) EQUITY
Current liabilities:
Current portion of capital lease obligations and    other financing arrangements	$	1,429		$	23,831	$	79,265	$	(79,229	)	$	25,296
Accrued payroll, accounts payable and accrued    expenses		78,168			182,536		66,304		(8,060	)		318,948
Intercompany payables		857,790			537,244		19,916		(1,414,950	)		—
Income taxes payable		—			449		3,380		—			3,829
Deferred revenue and client advances		—			189,789		56,832		—			246,621
Total current liabilities		937,387			933,849		225,697		(1,502,239	)		594,694
Capital lease obligations, net of current portion		—			45,512		13		—			45,525
Long-term debt, net of current portion		1,547,653			569,479		—		—			2,117,132
Non-current income tax liability		—			4,807		2,760		—			7,567
Deferred tax liability		74			77,854		1,178		—			79,106
Other non-current liabilities		12,902			31,599		22,249		—			66,750
Non-current intercompany liabilities		—			429,157		28,878		(458,035	)		—
Total liabilities		2,498,016			2,092,257		280,775		(1,960,274	)		2,910,774
Total inVentiv Health, Inc. stockholder’s deficit		(784,977	)		656,433		151,380		(807,813	)		(784,977	)
Noncontrolling interest		—			—		1,998		—			1,998
Total stockholder’s deficit		(784,977	)		656,433		153,378		(807,813	)		(782,979	)
Total liabilities and stockholder’s deficit	$	1,713,039		$	2,748,690	$	434,153	$	(2,768,087	)	$	2,127,795

CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION

At December 31, 2015

(in thousands, except share and per share amounts)

	inVentiv			Guarantor		Non-Guarantor
	Health, Inc.			Subsidiaries		Subsidiaries		Eliminations			Total
ASSETS
Current assets:
Cash and cash equivalents	$	55,226			—	$	148,970	$	(82,879	)	$	121,317
Restricted cash		226			—		1,381		—			1,607
Accounts receivable, net of allowances for    doubtful accounts		—			292,548		66,533		—			359,081
Unbilled services		—			174,070		33,395		—			207,465
Intercompany receivables		529,457			840,499		18,211		(1,388,167	)		—
Prepaid expenses and other current assets		8,839			11,401		22,690		—			42,930
Income tax receivable		104			—		1,076		(104	)		1,076
Total current assets		593,852			1,318,518		292,256		(1,471,150	)		733,476
Property and equipment, net		23,227			101,507		17,298		—			142,032
Goodwill		—			855,317		40,052		—			895,369
Intangible assets, net		—			328,239		6,407		—			334,646
Non-current deferred tax assets		—			—		10,032		—			10,032
Other assets		19,084			4,491		13,559		—			37,134
Non-current intercompany receivables		416,161			29,235		35,021		(480,417	)		—
Investment in consolidated subsidiaries		676,479			93,191		—		(769,670	)		—
Total assets	$	1,728,803		$	2,730,498	$	414,625	$	(2,721,237	)	$	2,152,689
LIABILITIES AND STOCKHOLDER’S (DEFICIT) EQUITY
Current liabilities:
Current portion of capital lease obligations and    other financing arrangements	$	1,936		$	21,324	$	73,355	$	(73,282	)	$	23,333
Accrued payroll, accounts payable and accrued    expenses		71,953			200,063		71,307		(9,597	)		333,726
Intercompany payables		820,965			542,500		24,702		(1,388,167	)		—
Income taxes payable		—			165		5,423		(104	)		5,484
Deferred revenue and client advances		—			190,828		55,828		—			246,656
Total current liabilities		894,854			954,880		230,615		(1,471,150	)		609,199
Capital lease obligations, net of current portion		—			45,247		11		—			45,258
Long-term debt, net of current portion		1,533,197			568,688		—		—			2,101,885
Non-current income tax liability		—			4,806		1,136		—			5,942
Deferred tax liability		74			73,047		239		—			73,360
Other non-current liabilities		38,494			30,896		18,763		—			88,153
Non-current intercompany liabilities		34,920			416,260		29,237		(480,417	)		—
Total liabilities		2,501,539			2,093,824		280,001		(1,951,567	)		2,923,797
Total inVentiv Health, Inc. stockholder’s deficit		(772,736	)		636,674		132,996		(769,670	)		(772,736	)
Noncontrolling interest		—			—		1,628		—			1,628
Total stockholder’s deficit		(772,736	)		636,674		134,624		(769,670	)		(771,108	)
Total liabilities and stockholder’s deficit	$	1,728,803		$	2,730,498	$	414,625	$	(2,721,237	)	$	2,152,689

Consolidating Statement of Operations

CONSOLIDATING STATEMENT OF OPERATIONS

Three Months Ended March 31, 2016

(in thousands)

	inVentiv			Guarantor			Non-Guarantor
	Health, Inc.			Subsidiaries			Subsidiaries			Eliminations			Total
Net revenues	$	—		$	419,336		$	129,933		$	(7,973	)	$	541,296
Reimbursed out-of-pocket expenses		—			83,818			7,214			(49	)		90,983
Total revenues		—			503,154			137,147			(8,022	)		632,279
Operating expenses:
Cost of revenues		—			300,392			79,298			(7,314	)		372,376
Reimbursable out-of-pocket expenses		—			83,818			7,214			(49	)		90,983
Selling, general and administrative expenses		21,129			71,369			31,917			(659	)		123,756
Allocation of intercompany costs		(13,899	)		10,915			2,984			—			—
Total operating expenses		7,230			466,494			121,413			(8,022	)		587,115
Operating income (loss)		(7,230	)		36,660			15,734			—			45,164
Gain on extinguishment of debt		221			—			—			—			221
Interest income (expense), net		(43,831	)		(12,277	)		255			—			(55,853	)
Intercompany interest income (expense)		12,975			(12,715	)		(260	)		—			—
Income (loss) before income tax (provision)    benefit and income (loss) from equity    investments		(37,865	)		11,668			15,729			—			(10,468	)
Income tax (provision) benefit		—			(5,145	)		(3,031	)		—			(8,176	)
Income (loss) before income (loss) from equity    investments		(37,865	)		6,523			12,698			—			(18,644	)
Income (loss) from equity investments		18,788			10,574			—			(29,357	)		5
Net income (loss)		(19,077	)		17,097			12,698			(29,357	)		(18,639	)
Less: Net (income) loss attributable to the    noncontrolling interest		—			—			(438	)		—			(438	)
Net income (loss) attributable to    inVentiv Health, Inc.	$	(19,077	)	$	17,097		$	12,260		$	(29,357	)	$	(19,077	)

CONSOLIDATING STATEMENT OF OPERATIONS

Three Months Ended March 31, 2015

(in thousands)

	inVentiv			Guarantor			Non-Guarantor
	Health, Inc.			Subsidiaries			Subsidiaries			Eliminations			Total
Net revenues	$	—		$	346,981		$	109,751		$	(5,755	)	$	450,977
Reimbursed out-of-pocket expenses		—			59,616			7,783			(76	)		67,323
Total revenues		—			406,597			117,534			(5,831	)		518,300
Operating expenses:
Cost of revenues		—			236,463			69,304			(5,262	)		300,505
Reimbursable out-of-pocket expenses		—			59,616			7,783			(76	)		67,323
Selling, general and administrative expenses		16,087			84,539			32,781			(493	)		132,914
Allocation of intercompany costs		(9,900	)		7,944			1,956			—			—
Total operating expenses		6,187			388,562			111,824			(5,831	)		500,742
Operating income (loss)		(6,187	)		18,035			5,710			—			17,558
Interest income (expense), net		(44,398	)		(12,169	)		104			—			(56,463	)
Intercompany interest income (expense)		11,122			(10,972	)		(150	)		—			—
Income (loss) before income tax (provision)    benefit and income (loss) from equity    investments		(39,463	)		(5,106	)		5,664			—			(38,905	)
Income tax (provision) benefit		—			(2,975	)		(1,553	)		—			(4,528	)
Income (loss) before income (loss) from equity    investments		(39,463	)		(8,081	)		4,111			—			(43,433	)
Income (loss) from equity investments		(5,622	)		1,630			—			2,463			(1,529	)
Net income (loss)		(45,085	)		(6,451	)		4,111			2,463			(44,962	)
Less: Net (income) loss attributable to the    noncontrolling interest		—			—			(123	)		—			(123	)
Net income (loss) attributable to inVentiv    Health, Inc.	$	(45,085	)	$	(6,451	)	$	3,988		$	2,463		$	(45,085	)

Consolidating Statement of Comprehensive Loss

CONSOLIDATING STATEMENT OF COMPREHENSIVE LOSS

Three Months Ended March 31, 2016

(in thousands)

	inVentiv			Guarantor		Non-Guarantor
	Health, Inc.			Subsidiaries		Subsidiaries			Eliminations			Total
Net Income (loss)	$	(19,077	)	$	17,097	$	12,698		$	(29,357	)	$	(18,639	)
Other comprehensive income (loss):
Foreign currency translation adjustment		5,419			2,662		6,119			(8,781	)		5,419
Total other comprehensive income (loss)		5,419			2,662		6,119			(8,781	)		5,419
Total comprehensive income (loss)		(13,658	)		19,759		18,817			(38,138	)		(13,220	)
Less: Comprehensive (income) loss    attributable to the noncontrolling interest		—			—		(438	)		—			(438	)
Total comprehensive income (loss) attributable to    inVentiv Health, Inc.	$	(13,658	)	$	19,759	$	18,379		$	(38,138	)	$	(13,658	)

CONSOLIDATING STATEMENT OF COMPREHENSIVE LOSS

Three Months Ended March 31, 2015

(in thousands)

	inVentiv			Guarantor			Non-Guarantor
	Health, Inc.			Subsidiaries			Subsidiaries			Eliminations		Total
Net Income (loss)	$	(45,085	)	$	(6,451	)	$	4,111		$	2,463	$	(44,962	)
Other comprehensive income (loss):
Foreign currency translation adjustment		(5,445	)		(5,435	)		(4,011	)		9,446		(5,445	)
Total other comprehensive income (loss)		(5,445	)		(5,435	)		(4,011	)		9,446		(5,445	)
Total comprehensive income (loss)		(50,530	)		(11,886	)		100			11,909		(50,407	)
Less: Comprehensive (income) loss    attributable to the noncontrolling interest		—			—			(123	)		—		(123	)
Total comprehensive income (loss) attributable to    inVentiv Health, Inc.	$	(50,530	)	$	(11,886	)	$	(23	)	$	11,909	$	(50,530	)

Condensed Consolidating Statement of Cash Flows

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Three Months Ended March 31, 2016

(in thousands)

	inVentiv			Guarantor			Non-Guarantor
	Health, Inc.			Subsidiaries			Subsidiaries			Eliminations			Total
Cash flows from operating activities:
Net cash provided by (used in) operating    activities	$	(36,631	)	$	15,585		$	19,486		$	(8,060	)	$	(9,620	)
Cash flows from investing activities:
Purchases of property and equipment		(1,811	)		(1,401	)		(2,958	)		—			(6,170	)
Proceeds from vehicle sales and rebates on    vehicle leases		—			3,979			—			—			3,979
Intercompany transfers		37,937			17,988			—			(55,925	)		—
Other, net		(1,491	)		—			525			—			(966	)
Net cash provided by (used in) investing activities		34,635			20,566			(2,433	)		(55,925	)		(3,157	)
Cash flows from financing activities:
Repayments on capital leases and other    financing arrangements		(972	)		(7,896	)		(39	)		—			(8,907	)
Repurchase of Notes		(22,790	)		—			—			—			(22,790	)
Payment on installment note and contingent    consideration related to acquisition		(2,174	)		—			—			—			(2,174	)
Intercompany transfers		—			(28,255	)		(31,320	)		59,575			—
Other, net		464			—			(68	)		—			396
Net cash provided by (used in) financing activities		(25,472	)		(36,151	)		(31,427	)		59,575			(33,475	)
Effects of foreign currency exchange rate changes    on cash		—			—			2,048			—			2,048
Net increase (decrease) in cash and cash    equivalents		(27,468	)		—			(12,326	)		(4,410	)		(44,204	)
Cash and cash equivalents, beginning of period		55,226			—			148,970			(82,879	)		121,317
Cash and cash equivalents, end of period	$	27,758		$	—		$	136,644		$	(87,289	)	$	77,113

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Three Months Ended March 31, 2015

(in thousands)

	inVentiv			Guarantor			Non-Guarantor
	Health, Inc.			Subsidiaries			Subsidiaries			Eliminations			Total
Cash flows from operating activities:
Net cash provided by (used in) operating    activities	$	(37,855	)	$	37,407		$	8,984		$	(6,385	)	$	2,151
Cash flows from investing activities:
Purchases of property and equipment		(2,777	)		(5,199	)		(1,823	)		—			(9,799	)
Proceeds from vehicle sales and rebates on    vehicle leases		—			3,093			—			—			3,093
Intercompany transfers		51,656			—			—			(51,656	)		—
Other, net		(238	)		—			—			—			(238	)
Net cash provided by (used in) investing activities		48,641			(2,106	)		(1,823	)		(51,656	)		(6,944	)
Cash flows from financing activities:
Repayments on capital leases and other    financing arrangements		(983	)		(7,816	)		(125	)		—			(8,924	)
Borrowings under line of credit		17,000			—			—			—			17,000
Repayments on line of credit		(17,000	)		—			—			—			(17,000	)
Payment on installment note and contingent    consideration related to acquisition		(1,917	)		—			—			—			(1,917	)
Intercompany transfers		—			(30,924	)		6,980			23,944			—
Other, net		93			—			(68	)		—			25
Net cash provided by (used in) financing activities		(2,807	)		(38,740	)		6,787			23,944			(10,816	)
Effects of foreign currency exchange rate changes    on cash		—			—			(2,797	)		—			(2,797	)
Net increase (decrease) in cash and cash    equivalents		7,979			(3,439	)		11,151			(34,097	)		(18,406	)
Cash and cash equivalents, beginning of period		19,643			3,439			86,014			(52,037	)		57,059
Cash and cash equivalents, end of period	$	27,622		$	—		$	97,165		$	(86,134	)	$	38,653